Overview
Product name | Biotinylated Recombinant Human HBV(HLA-A*02:01) Protein |
---|
Catalog No. | RP02754 |
---|
Description | Recombinant Biotinylated Human HBV(HLA-A*02:01) Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal;It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and FLLTRILTI peptide. |
---|
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
---|
Endotoxin | Less than 1EU per μg by the LAL method. |
---|
Species | Human |
---|
Calculated MW | 50.5 kDa |
---|
Background
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7).
Product information
Synonym | Hepatitis B virus; MHC; HBV |
---|
Expression Host | HEK293 cells |
---|
Tag | C-His&Avi |
---|
Swiss-Prot | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.